GPCRs-Targeted Drug Discovery Summit Leaderboard
  • Monday, May 11, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Obesity & Weight Loss Drug Development Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 516

Lilly Statement on Novel Coronavirus and the Reliable Supply of the Company’s Medicines

Mar 3, 2020
Eli Lilly and Company issued the following statement today regarding the novel coronavirus: Among the concerns raised due to the impact of the novel coronavirus is whether patients…
Read More...

Completion of Study Enrolment of Implandata’s Extraocular Eye Pressure Sensor for Continual Glaucoma…

Mar 3, 2020
Ophthalmic medical device company Implandata Ophthalmic Products GmbH (Implandata) announced that study enrolment of its international ARGOS-SC01 clinical study was completed with the…
Read More...

CYTOO and AskBio Enter Research Agreement to Screen Gene Therapy Candidates for Rare Muscle Disorder

Mar 3, 2020
CYTOO announced that it has entered into a research collaboration aimed at selecting a gene therapy candidate for a rare muscle disorder with Asklepios BioPharmaceutical, Inc. (AskBio),…
Read More...

AstraZeneca completes divestment agreement with Atnahs Pharma for established hypertension medicines

Mar 3, 2020
AstraZeneca announced that it has completed the previously communicated agreement with Atnahs Pharma (Atnahs) to divest its global commercial rights to Inderal (propranolol), Tenormin…
Read More...

Mateon Provides Update on its Rapid Antiviral Response Program Initially Targeting COVID-19

Mar 3, 2020
Mateon Therapeutics, Inc. dedicated to development OT-101, a TGF-Beta antisense drug candidate, provided an update on its rapid antiviral response program initially targeting the…
Read More...

What to expect for SMi’s AI in Drug Discovery Conference – 2 weeks to go

Mar 3, 2020
SMi Reports: Conference highlights for AI in Drug Discovery conference taking place in London, this March. With less than 2 weeks to go for the highly anticipated AI in Drug…
Read More...

Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target…

Mar 2, 2020
Samsung Biologics (207940.KS) and STCube announced a strategic development and manufacturing service agreement for STT-003 antibody, an anti-cancer drug candidate. Under the…
Read More...

Gilead to Acquire Forty Seven for $4.9 Billion

Mar 2, 2020
Gilead Sciences, Inc. and Forty Seven, Inc. announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Forty Seven for $95.50 per share…
Read More...

Takeda Agrees to Divest Select OTC and Non-Core Assets in Latin America to Hypera Pharma

Mar 2, 2020
Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select non-core products exclusively in Latin America to Hypera S.A.,…
Read More...

FDA Grants Breakthrough Therapy Designation for Genentech’s Esbriet (pirfenidone) in uILD

Mar 2, 2020
Genentech, a member of the Roche Group announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Esbriet (pirfenidone) for adults with…
Read More...
Previous 1 … 514 515 516 517 518 … 924 Next
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
GPCRs-Targeted Drug Discovery Summit
5th World ADC Summit South Korea
Extrahepatic Lipid-Based Nanoparticles Delivery Summit
World TPD & Induced Proximity Summit South Korea
Measuring Patient Engagement Summit
Investigative & Preclinical Toxicology Summit 2026
LEAP HR: Life Sciences West
Oligonucleotides for CNS Summit
R&D Procurement & Sourcing in Pharma Summit
In Vivo Cell Engineering & Gene Editing Summit
PFS & Injectable Drug Delivery West Coast
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
World Bispecific & T-Cell Engager Summit South Korea
TCR-Based Therapies Summit
PFS & Injectable Drug Devices East Coast
5th ADC Analytical Development Summit
Nasal Formulation & Delivery Summit
Peptide-Based Therapeutics Summit 2026
ALS Drug Development Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Roche Acquires PathAI to Expand Digital Pathology Business
  • Altasciences, Certara Partner to Speed Early Drug Development
  • Angelini Pharma to Acquire Catalyst in $4.1 Billion Deal
  • Novartis Breaks Ground on Texas Cancer Therapy Facility
  • Lilly Expands Indiana Manufacturing With $4.5 Billion Investment

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

Turning Biophysical Data into Confident Drug Discovery…

Targeted LNP Delivery Beyond the Liver: The Challenges…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.